Liquidia CORP Form 4 insider transactions
NASDAQ
LQDA
Liquidia CORPLiquidia Corp Director Paul B. Manning sold 670,837 shares of common stock across multiple transactions in late August and early September 2025, totaling approximately $18.96 million.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reported multiple transactions including RSU conversions and sales under pre-arranged 10b5-1 plans.
NASDAQ
LQDA
Liquidia CORPLiquidia Corporation's Chief Medical Officer, Rajeev Saggar, sold 20,000 shares of common stock for approximately $27.85 per share, executed under a pre-arranged 10b5-1 trading plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp Director Joanna Horobin sold 5,000 shares of common stock for $27.17 per share under a pre-arranged trading plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO and COO, Michael Kaseta, sold 20,000 shares of common stock for $26.1837 per share under a pre-arranged 10b5-1 trading plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CFO and COO, Michael Kaseta, sold 30,000 shares of common stock for approximately $20.00 per share under a pre-arranged 10b5-1 plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corporation's Chief Business Officer, Jason Adair, filed a Form 4 detailing a future sale of 454 shares of common stock to cover tax liabilities from restricted stock unit settlements.
NASDAQ
LQDA
Liquidia CORPLiquidia Corporation's Chief Accounting Officer, Dana Boyle, sold 1,063 shares of common stock at $19.54 per share to cover tax obligations related to vested restricted stock units, as part of a pre-arranged 10b5-1 plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corporation's Chief Medical Officer, Rajeev Saggar, sold 2,526 shares of common stock at $14.54 per share on July 21, 2025, to cover tax liabilities from restricted stock unit vesting.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reported the acquisition of common stock through PSU conversion and a subsequent sale of shares to cover tax obligations, all under a pre-arranged Rule 10b5-1 plan.
NASDAQ
LQDA
Liquidia CORPForm 4: Liquidia Corp Chief Medical Officer Reports Routine Equity Transactions and Tax-Related Stock Sale
Liquidia Corp's Chief Medical Officer, Rajeev Saggar, reported the conversion of performance stock units into common stock and a subsequent sale of shares to cover tax obligations, executed under a pre-arranged trading plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Commercial Officer, Scott Moomaw, exercised performance stock units and subsequently sold a portion of common stock to cover tax obligations, as disclosed in a recent Form 4 filing.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Human Resource Officer, Sarah Krepp, sold 2,673 shares of common stock at $14.28 per share on July 14, 2025, to cover tax obligations related to restricted stock unit settlements.
NASDAQ
LQDA
Liquidia CORPLiquidia Corporation's CFO and COO, Michael Kaseta, reported the acquisition of common stock from performance stock unit conversion and subsequent sale of shares to cover tax obligations, all executed under a pre-arranged Rule 10b5-1 plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CEO, Roger Jeffs, reported the conversion of performance stock units and a subsequent sale of common stock to cover tax obligations, as detailed in a recent SEC Form 4 filing.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's CEO, Roger Jeffs, reported the conversion of performance stock units and a subsequent sale of common stock to cover tax obligations, as detailed in a recent SEC Form 4 filing.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Accounting Officer, Dana Boyle, sold 1,193 shares of common stock at $14.28 per share on July 14, 2025, to cover tax liabilities related to restricted stock unit settlements.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Business Officer, Jason Adair, reported the acquisition of common stock through PSU conversion and a subsequent sale of shares to cover tax obligations, as part of a pre-arranged trading plan.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Human Resource Officer, Sarah Krepp, was granted 25,000 restricted stock units (RSUs) on July 1, 2025, as part of her compensation.
NASDAQ
LQDA
Liquidia CORPForm 4: Liquidia Corp Chief Accounting Officer Receives Significant RSU Grant, Boosting Beneficial Ownership
Liquidia Corp's Chief Accounting Officer, Dana Boyle, was granted 25,000 restricted stock units (RSUs), increasing her total beneficial ownership in the company to 188,361 shares.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp Director Raman Singh was granted 18,396 restricted stock units (RSUs), increasing his beneficial ownership to 38,755 shares.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Director, Katherine Rielly-Gauvin, has been granted 18,396 restricted stock units, increasing her beneficial ownership in the company.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp Director and 10% owner Paul B. Manning reported a substantial decrease in his beneficial ownership, primarily due to the disposition of over 3.1 million common shares, alongside the acquisition of new restricted stock units.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp Director Arthur S. Kirsch was granted 18,396 restricted stock units (RSUs) effective June 17, 2025, as reported in a recent SEC Form 4 filing.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp Director Joanna Horobin was granted 18,396 Restricted Stock Units (RSUs) on June 17, 2025, increasing her beneficial ownership to 38,755 shares of common stock.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp Director Damian deGoa has reported the acquisition of 18,396 restricted stock units (RSUs) on June 17, 2025, increasing his beneficial ownership to 86,471 shares.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp. Director Stephen M. Bloch was granted 18,396 Restricted Stock Units (RSUs) on June 17, 2025, as part of his compensation, which will convert to common stock upon vesting.
NASDAQ
LQDA
Liquidia CORPDavid Johnson, a Director and 10% owner of Liquidia Corp, was granted 18,396 restricted stock units, increasing his beneficial ownership in the company.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's General Counsel, Russell Schundler, reported the acquisition of common stock through performance stock unit vesting and a subsequent sale of shares to cover tax obligations, as detailed in a recent SEC Form 4 filing.
NASDAQ
LQDA
Liquidia CORPLiquidia Corp's Chief Commercial Officer, Scott Moomaw, reported the acquisition of 15,539 shares of common stock from vested performance stock units and the subsequent sale of 6,656 shares at $16.97 to cover tax obligations.